ADAM 12 may be used to reduce the false positive rate of first trimester combined screening for Down syndrome

Michael Christiansen, Kasper Pihl, Paula L. Hedley, Anne-Cathrine Gjerris, Pia Ø Lind, Severin Olesen Larsen, Lone Krebs, Torben Larsen

13 Citationer (Scopus)

Fingeraftryk

Dyk ned i forskningsemnerne om 'ADAM 12 may be used to reduce the false positive rate of first trimester combined screening for Down syndrome'. Sammen danner de et unikt fingeraftryk.

Medicin og biovidenskab